Recent research suggests that common steroids could significantly reduce the risk of death in patients recovering from long COVID. According to a study featured by Frontiers, steroid use post-recovery may lower mortality by up to 51%. This finding highlights a potential breakthrough in long COVID care and long-term patient outcomes.
The study examined patients who continued to struggle with symptoms after their initial COVID-19 infection. Researchers found that certain anti-inflammatory steroid treatments helped reduce persistent inflammation, a key factor in ongoing complications. As long COVID continues to affect millions globally, this discovery may offer a path to more effective post-recovery treatment protocols.
To learn more about this research, read the full article here: Common steroids after ‘long Covid’ recovery may cut risk of death by up to 51% Courtesy of Frontiers.